Roger Dansey - 13 Mar 2023 Form 4 Insider Report for Seagen Inc. (SGEN)

Role
President, R&D & CMO
Signature
By: /s/ Jennifer Prosba For: Roger D. Dansey
Issuer symbol
SGEN
Transactions as of
13 Mar 2023
Transactions value $
-$14,662
Form type
4
Date filed
22 Sep 2023, 20:51
Previous filing
17 Feb 2023
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Award $0 +1.66K +1.71% $0.00 98.5K 13 Mar 2023 Direct F1, F2
transaction SGEN Common Stock Award $0 +3.32K +3.27% $0.00 105K 05 Apr 2023 Direct F1, F2
transaction SGEN Common Stock Sale -$14.7K -71 -0.06% $206.50 117K 21 Sep 2023 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units and will be settled in common stock upon vesting.
F2 The performance criteria for these restricted stock units were met. These restricted stock units will become fully vested on 1/15/2024, subject to continuous service with the Company until the vesting date
F3 The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/4/2021 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F4 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.